BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30418670)

  • 1. Time interval between antibody investigations among patients who demonstrate serial red cell antibody formation.
    Dinh A; Eliason K; Dzik WS
    Transfusion; 2019 Feb; 59(2):738-743. PubMed ID: 30418670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloimmunization in neonates and children up to 3 years of age.
    Türkmen T; Qiu D; Cooper N; Sachs UJ; Wößmann W; Schranz D; Zimmer KP; Ehrhardt H; Hackstein H; Bein G
    Transfusion; 2017 Nov; 57(11):2720-2726. PubMed ID: 28880379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.
    Schonewille H; van de Watering LM; Loomans DS; Brand A
    Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.
    Schonewille H; Doxiadis II; Levering WH; Roelen DL; Claas FH; Brand A
    Transfusion; 2014 Aug; 54(8):1971-80. PubMed ID: 24654685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody of undetermined specificity: frequency, laboratory features, and natural history.
    Liu C; Grossman BJ
    Transfusion; 2013 May; 53(5):931-8. PubMed ID: 23305295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBC antibody persistence.
    Schonewille H; Haak HL; van Zijl AM
    Transfusion; 2000 Sep; 40(9):1127-31. PubMed ID: 10988317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressants and alloimmunization against red blood cell transfusions.
    Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
    Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specificity and clinical features of erythrocytic allo-antibodies in hospitalized patients].
    Wu BT; Yao DG; Rong RM
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1691-3. PubMed ID: 21914318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?
    de La Rubia J; Arriaga F; Andreu R; Sanz G; Jiménez C; Vicente A; Carpio N; Marty ML; Sanz MA
    Transfusion; 2001 Jan; 41(1):106-10. PubMed ID: 11161254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda.
    Eipl K; Nakabiito C; Bwogi K; Motevalli M; Roots A; Blagg L; Jackson JB
    Immunohematology; 2012; 28(4):115-7. PubMed ID: 23421539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the interval between antibody identifications be increased for alloimmunized patients?
    Goss C; Avecilla ST; Garbaini J; Degtyaryova D; Lo D; Chang DY; Cushing M
    Transfusion; 2016 Feb; 56(2):334-8. PubMed ID: 26456540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota.
    Winters JL; Pineda AA; Gorden LD; Bryant SC; Melton LJ; Vamvakas EC; Moore SB
    Transfusion; 2001 Nov; 41(11):1413-20. PubMed ID: 11724988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study.
    Seltsam A; Wagner F; Lambert M; Bullock T; Thornton N; Scharberg EA; Grueger D; Schneeweiss C; Blasczyk R
    Transfusion; 2014 Jul; 54(7):1823-30. PubMed ID: 24635443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence.
    Stack G; Tormey CA
    Transfusion; 2016 Nov; 56(11):2662-2667. PubMed ID: 27394029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M; Dziegiel M; Hegaard HK; Bidstrup M; Jonsbo F; Christensen B; Hedegaard M
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody identification using both automated solid-phase red cell adherence assay and a tube polyethylene glycol antiglobulin method.
    Yamada C; Serrano-Rahman L; Vasovic LV; Mohandas K; Uehlinger J
    Transfusion; 2008 Aug; 48(8):1693-8. PubMed ID: 18482178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption and elution of anti-Hy from one of four Gy(a-) human red blood cell samples.
    Reid ME; Ellisor SS; Sabo B
    Transfusion; 1982; 22(6):528-31. PubMed ID: 7147332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Percentage of Evanescent Red Cell Antibodies in Patients with Sickle Cell Disease Highlights Need for a National Antibody Database.
    Williams LA; Lorenz RG; Tahir A; Pham HP; Marques MB
    South Med J; 2016 Sep; 109(9):588-91. PubMed ID: 27598370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.